Clinical Trial Information

Trial Number: NCT00134056 (
Disease Type:
  • Reproductive System Neoplasm, Male - Prostate Cancer
Trial Title:
Phase III Study of Docetaxel and Atrasentan Versus Docetaxel and Placebo for Patients With Advanced Hormone Refractory Prostate Cancer
Study ID:
Images are available?:
Is this a NCI-MATCH Trial?:

Datasets Linked to Trial

Title Description
NCT00134056-D1 This dataset contains quality of life (QOL) data from trial NCT00134056 to reproduce the results reported in the Journal of Patient-Reported Outcomes (Unger et al, JPRO, 2018, PMID29951640).